297 related articles for article (PubMed ID: 30772440)
1. Complementary Relation Between the Improvement of Dose Delivery Technique and PTV Margin Reduction in Dose-Escalated Radiation Therapy for Prostate Cancer.
Utsunomiya S; Yamamoto J; Tanabe S; Oishi M; Satsuma A; Kaidu M; Abe E; Ohta A; Kushima N; Aoyama H
Pract Radiat Oncol; 2019 May; 9(3):172-178. PubMed ID: 30772440
[TBL] [Abstract][Full Text] [Related]
2. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
[TBL] [Abstract][Full Text] [Related]
3. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
4. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer.
Martinez AA; Yan D; Lockman D; Brabbins D; Kota K; Sharpe M; Jaffray DA; Vicini F; Wong J
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1226-34. PubMed ID: 11483333
[TBL] [Abstract][Full Text] [Related]
5. Conformal irradiation of concave-shaped PTVs in the treatment of prostate cancer by simple 1D intensity-modulated beams.
Fiorino C; Broggi S; Corletto D; Cattaneo GM; Calandrino R
Radiother Oncol; 2000 Apr; 55(1):49-58. PubMed ID: 10788688
[TBL] [Abstract][Full Text] [Related]
6. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
7. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma.
Scobioala S; Kittel C; Elsayad K; Kroeger K; Oertel M; Samhouri L; Haverkamp U; Eich HT
Radiat Oncol; 2019 Aug; 14(1):143. PubMed ID: 31399115
[TBL] [Abstract][Full Text] [Related]
8. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
[No Abstract] [Full Text] [Related]
9. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
Kassim I; Dirkx ML; Heijmen BJ
Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
[TBL] [Abstract][Full Text] [Related]
11. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
[TBL] [Abstract][Full Text] [Related]
12. IMRT: improvement in treatment planning efficiency using NTCP calculation independent of the dose-volume-histogram.
Grigorov GN; Chow JC; Grigorov L; Jiang R; Barnett RB
Med Phys; 2006 May; 33(5):1250-8. PubMed ID: 16752559
[TBL] [Abstract][Full Text] [Related]
13. Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer.
Pinkawa M; Corral NE; Caffaro M; Piroth MD; Holy R; Djukic V; Otto G; Schoth F; Eble MJ
Radiother Oncol; 2011 Sep; 100(3):436-41. PubMed ID: 21963289
[TBL] [Abstract][Full Text] [Related]
14. Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer.
Yeo I; Nookala P; Gordon I; Schulte R; Barnes S; Ghebremedhin A; Wang N; Yang G; Ling T; Bush D; Slater J; Patyal B
Radiat Oncol; 2015 Oct; 10():213. PubMed ID: 26499318
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
[TBL] [Abstract][Full Text] [Related]
16. Rectal complication probability from composite volumes derived from daily cone beam computed tomography in prostate cancer radiotherapy.
Prabhakar R; Oates R; Daryl J; Chang J; Geso M; Cramb J
J Cancer Res Ther; 2016; 12(1):374-8. PubMed ID: 27072266
[TBL] [Abstract][Full Text] [Related]
17. The role and strategy of IMRT in radiotherapy of pelvic tumors: Dose escalation and critical organ sparing in prostate cancer.
Liu YM; Shiau CY; Lee ML; Huang PI; Hsieh CM; Chen PH; Lin YH; Wang LW; Yen SH
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1113-23. PubMed ID: 17197126
[TBL] [Abstract][Full Text] [Related]
18. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
[TBL] [Abstract][Full Text] [Related]
19. Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions.
Murray LJ; Lilley J; Thompson CM; Cosgrove V; Mason J; Sykes J; Franks K; Sebag-Montefiore D; Henry AM
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):406-15. PubMed ID: 24685447
[TBL] [Abstract][Full Text] [Related]
20. The effect of changing technique, dose, and PTV margin on therapeutic ratio during prostate radiotherapy.
Huang SH; Catton C; Jezioranski J; Bayley A; Rose S; Rosewall T
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1057-64. PubMed ID: 18339487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]